West Enclave completes $119M SPAC IPO, begins search for business combination target

Filed June 10, 2026 · Period ending March 31, 2026 · ~1 min read

Key Changes

• high

  Company raised $119.25M through May 2026 IPO and private placement, with $116.15M held in trust to fund future business combination. Over-allotment option exercised in full for additional $15M.

  MD&A: IPO and Trust Account verify on EDGAR →
• high

  Deferred underwriting fee of 3.5% of gross proceeds (~$4M) payable to EBC upon deal completion will reduce available capital for the combined entity.

  MD&A: Underwriting Fees verify on EDGAR →
• high

  High shareholder redemptions could force additional financing through equity or debt, potentially on unfavorable terms or causing dilution to remaining holders.

  MD&A: Redemption Risk verify on EDGAR →